实验方案(Protocols)

Viral DNA/RNA Rapid Extraction Kit: Protocol & Usage Guide

Viral DNA/RNA Rapid Extraction Kit is a fast and reliable reagent system designed to isolate high-quality viral DNA and RNA from diverse biological samples in a streamlined, column-based workflow suitable for downstream molecular applications.

SKU
D1128032
Product Name
Viral DNA/RNA Rapid Extraction Kit
Nucleic Acid Targets
Viral DNA and RNA (simultaneous or individual extraction)
Sample Types
Serum, plasma, whole blood, swabs, cell-free body fluids, and other viral-containing samples
Workflow Format
Spin-column based, no phenol-chloroform required
Downstream Compatibility
RT-PCR, qPCR, sequencing, NGS library preparation
Storage Condition
Store reagents at indicated temperatures; refer to kit insert for component-specific requirements

Kit Overview and Principle

The Viral DNA/RNA Rapid Extraction Kit (D1128032) from Aladdin Scientific is engineered to provide fast, efficient isolation of both viral DNA and RNA from a wide range of biological specimens. The kit utilizes a silica membrane spin-column format that selectively binds nucleic acids under chaotropic salt conditions, enabling the removal of proteins, lipids, and other contaminants through a series of wash steps before final elution of purified nucleic acids in a low-salt buffer or nuclease-free water.

Chaotropic lysis buffers rapidly inactivate nucleases (RNases and DNases) upon sample contact, protecting the integrity of viral RNA—which is especially labile—during processing. The simplified column-based workflow eliminates the need for hazardous organic solvents such as phenol and chloroform, improving laboratory safety and throughput. The resulting eluate is suitable for sensitive downstream applications including reverse-transcription PCR (RT-PCR), quantitative PCR (qPCR), Sanger sequencing, and next-generation sequencing (NGS) library preparation.

Required Materials and Equipment

Provided in the kit:

  • Lysis/Binding Buffer (chaotropic, contains guanidinium salt)
  • Wash Buffer 1 (protein and inhibitor removal)
  • Wash Buffer 2 (ethanol-based; ensure ethanol is added before first use as indicated on the bottle label)
  • Elution Buffer (low-salt, nuclease-free) or nuclease-free water
  • Silica membrane spin columns
  • Collection tubes (2 mL)
  • Carrier RNA (if included; add to Lysis Buffer before use to enhance recovery of low-copy viral nucleic acids)

Required but not provided:

  • Microcentrifuge capable of ≥10,000 × g
  • Vortex mixer
  • 100% ethanol (molecular biology grade)
  • Nuclease-free 1.5 mL microcentrifuge tubes for eluate collection
  • Pipettes and nuclease-free aerosol-barrier tips
  • Personal protective equipment (gloves, lab coat, eye protection)
  • Optional: heating block or water bath set to 56–70 °C for enhanced lysis

Step-by-Step Extraction Protocol

Important notes before starting: Ensure Wash Buffer 2 has been supplemented with the required volume of 100% ethanol as indicated on the bottle. If carrier RNA is supplied, prepare the working Lysis Buffer by adding carrier RNA to the recommended concentration. Pre-warm Elution Buffer to 70 °C to maximize nucleic acid yield. Work on ice when processing RNA-containing samples to minimize degradation.

  1. Sample Lysis: Add the recommended volume of Lysis/Binding Buffer to the sample (e.g., 200 µL serum or plasma). Mix thoroughly by vortexing for 15 seconds. If required by the protocol, incubate at 56–70 °C for 10 minutes to ensure complete lysis and nuclease inactivation.
  2. Ethanol Addition: Add the specified volume of 100% ethanol to the lysate. Mix by vortexing or pipetting to homogenize. This step promotes nucleic acid binding to the silica membrane.
  3. Column Loading: Transfer the entire lysate-ethanol mixture onto the silica membrane spin column seated in a 2 mL collection tube. Centrifuge at 8,000–10,000 × g for 1 minute. Discard the flow-through and reinsert the column into the collection tube. If the lysate volume exceeds column capacity, load in successive aliquots, centrifuging after each addition.
  4. First Wash: Add the specified volume of Wash Buffer 1 to the column. Centrifuge at 8,000–10,000 × g for 1 minute. Discard the flow-through.
  5. Second Wash: Add the specified volume of Wash Buffer 2 (ethanol-supplemented) to the column. Centrifuge at 8,000–10,000 × g for 1 minute. Discard the flow-through.
  6. Membrane Drying: Centrifuge the empty column at maximum speed (≥10,000 × g) for 2 minutes to remove residual ethanol, which can inhibit downstream enzymatic reactions.
  7. Elution: Transfer the spin column to a fresh, labeled nuclease-free 1.5 mL collection tube. Apply pre-warmed Elution Buffer (or nuclease-free water) directly to the center of the membrane. Incubate at room temperature for 1–3 minutes. Centrifuge at 8,000–10,000 × g for 1 minute. The eluate contains purified viral DNA/RNA. For higher yield, perform a second elution with an additional volume of Elution Buffer.
  8. Storage: Immediately place eluate on ice for short-term use. For long-term storage, freeze RNA eluates at −70 °C and DNA eluates at −20 °C. Avoid repeated freeze-thaw cycles.

Quality Control and Downstream Verification

After extraction, assess nucleic acid quality and quantity using the following approaches before proceeding to downstream applications:

  • Spectrophotometric Analysis: Measure absorbance at 260 nm (A260) and 280 nm (A280) using a microvolume spectrophotometer (e.g., NanoDrop). Pure RNA preparations typically exhibit an A260/A280 ratio of approximately 2.0; pure DNA preparations typically exhibit a ratio of approximately 1.8. Ratios significantly outside these ranges may indicate protein or solvent contamination. Also measure A260/A230 to assess chaotropic salt or organic solvent carryover; acceptable values are generally ≥1.8.
  • Fluorometric Quantification: For low-concentration or highly diluted eluates, fluorometric assays (e.g., Qubit RNA HS or DNA HS assays) provide more sensitive and accurate quantification than spectrophotometry.
  • Functional Verification: The most reliable quality check is a functional downstream assay. Spike-in internal controls (e.g., a defined copy number of an exogenous RNA or DNA control) added prior to lysis allow assessment of extraction efficiency and detection of PCR inhibitors. Include a no-template negative control and, where available, a positive extraction control in every run.
  • Gel Electrophoresis (optional): For RNA integrity assessment, run samples on a denaturing agarose gel or use a microfluidic capillary electrophoresis system (e.g., Agilent Bioanalyzer or TapeStation) to observe ribosomal RNA bands and obtain an RNA Integrity Number (RIN). For viral RNA from cell-free samples (serum, plasma), prominent rRNA bands are not expected; intact viral RNA is inferred from successful amplification of target sequences.

Troubleshooting Common Issues

Consult the table below when encountering suboptimal results:

ProblemProbable CauseRecommended Action
Low nucleic acid yieldInsufficient lysis; ethanol omitted from Wash Buffer 2; elution buffer not pre-warmed; low viral load in sampleEnsure Wash Buffer 2 is ethanol-supplemented; pre-warm elution buffer; use carrier RNA; perform a second elution; confirm sample quality
PCR inhibition / no amplificationResidual ethanol from incomplete membrane drying; chaotropic salt carryover due to skipped wash stepExtend dry-spin step to 3–5 minutes; do not skip any wash step; dilute eluate 1:5–1:10 and re-test
Low A260/A280 ratioProtein contamination; insufficient washRepeat wash steps; ensure correct centrifugation speed and duration
Low A260/A230 ratioResidual chaotropic salts or organic compoundsRepeat Wash Buffer 1 step; ensure ethanol is properly added to Wash Buffer 2
RNA degradationRNase contamination from pipettes, tubes, or operator; delayed processingUse certified RNase-free consumables and nuclease-free water; work on ice; process samples promptly after collection; wear fresh gloves throughout
Cross-contaminationAerosol generation during vortexing; reuse of collection tubesUse aerosol-barrier tips; never reuse collection tubes; perform extractions in a dedicated clean area separate from PCR setup

Frequently asked questions

Can the Viral DNA/RNA Rapid Extraction Kit be used with both serum and swab samples?

Yes. The kit is designed for use with diverse biological sample types including serum, plasma, nasopharyngeal or oropharyngeal swabs (eluted in viral transport media), whole blood, and other cell-free body fluids. Adjust input volume and lysis buffer volume according to the kit insert recommendations for each sample matrix.

Why is carrier RNA recommended, and how should it be prepared?

Carrier RNA (typically poly-A RNA or MS2 phage RNA) is added to the Lysis Buffer to improve the recovery of low-abundance viral nucleic acids by occupying non-specific binding sites on the silica membrane and co-precipitating with target nucleic acids. Prepare a working stock by dissolving lyophilized carrier RNA in nuclease-free water to the concentration specified in the kit insert, then add the recommended volume directly to the Lysis Buffer immediately before use. Store unused carrier RNA stocks at −70 °C.

How should extracted viral RNA be stored to prevent degradation?

Viral RNA is highly susceptible to RNase-mediated degradation. For short-term storage (up to 24 hours), keep the eluate on ice or at 4 °C. For long-term storage, aliquot the RNA into single-use volumes to avoid repeated freeze-thaw cycles and store at −70 °C (preferred) or −80 °C. Avoid storing RNA at −20 °C for extended periods, as standard −20 °C freezers with auto-defrost cycles can cause temperature fluctuations that degrade RNA.

What is the maximum recommended input sample volume for this kit?

Refer to the kit insert for the precise recommended input volume for each sample type, as maximum volume may vary by sample matrix. Typical input volumes for serum or plasma are in the range of 140–200 µL per extraction column, but always follow the specific instructions provided with the kit to ensure optimal performance.

Is this kit compatible with automated liquid handling platforms?

Many spin-column kits of this type can be adapted for semi-automated or fully automated nucleic acid extraction platforms. Consult Aladdin Scientific technical support for validated automation protocols and compatible instruments, as specific adaptation may require optimization of volumes and centrifugation or vacuum settings.

References

  1. Boom R, et al. Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology. 1990;28(3):495-503. PMID:1691208
  2. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nature Protocols. 2006;1(2):581-585. doi:10.1038/nprot.2006.83
  3. Aladdin Scientific. Viral DNA/RNA Rapid Extraction Kit (D1128032) Product Page. Aladdin Scientific Official Website.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Viral DNA/RNA Rapid Extraction Kit: Protocol & Usage Guide》. 阿拉丁知识库,更新于 2026年10月22日。 https://www.aladdin-e.com/zh_cn/faqs/viral-dna-rna-rapid-extraction-kit-protocol-usage-guide-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助